GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Starry Pharmaceutical Co Ltd (SHSE:603520) » Definitions » Market Cap

Zhejiang Starry Pharmaceutical Co (SHSE:603520) Market Cap : ¥3,249 Mil (As of Sep. 20, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Zhejiang Starry Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Zhejiang Starry Pharmaceutical Co's share price for the quarter that ended in Jun. 2024 was ¥9.54. Zhejiang Starry Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 438 Mil. Therefore, Zhejiang Starry Pharmaceutical Co's market cap for the quarter that ended in Jun. 2024 was ¥4,182 Mil.

Zhejiang Starry Pharmaceutical Co's quarterly market cap increased from Dec. 2023 (¥4,823 Mil) to Mar. 2024 (¥5,278 Mil) but then declined from Mar. 2024 (¥5,278 Mil) to Jun. 2024 (¥4,182 Mil).

Zhejiang Starry Pharmaceutical Co's annual market cap declined from Dec. 2021 (¥15,926 Mil) to Dec. 2022 (¥6,711 Mil) and declined from Dec. 2022 (¥6,711 Mil) to Dec. 2023 (¥4,823 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Zhejiang Starry Pharmaceutical Co's Enterprise Value for Today is ¥5,101 Mil.


Zhejiang Starry Pharmaceutical Co Market Cap Historical Data

The historical data trend for Zhejiang Starry Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Starry Pharmaceutical Co Market Cap Chart

Zhejiang Starry Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,135.69 16,122.09 15,926.12 6,710.83 4,822.60

Zhejiang Starry Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,719.81 5,295.27 4,822.60 5,278.46 4,182.43

Competitive Comparison of Zhejiang Starry Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Starry Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Starry Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Starry Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Zhejiang Starry Pharmaceutical Co's Market Cap falls into.



Zhejiang Starry Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Zhejiang Starry Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥14.08*342.514
=¥4,823

Zhejiang Starry Pharmaceutical Co's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=¥9.54*438.41
=¥4,182

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Starry Pharmaceutical Co  (SHSE:603520) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Zhejiang Starry Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Zhejiang Starry Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Starry Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.1 Sitali Avenue, Modern Industrial Gathering District, Zhejiang Province, Xianju County, Taizhou City, CHN, 317306
Zhejiang Starry Pharmaceutical Co Ltd is engaged in R&D, manufacture and marketing of active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series.
Executives
Hu Jin Sheng Director

Zhejiang Starry Pharmaceutical Co Headlines

No Headlines